Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 244 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 369 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 335 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 218 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 262 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 284 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 437 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 549 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 0.0 | BCD100322A01 | 378 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 0.5 | BCD100322A03 | 360 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 1.0 | BCD100322A07 | 461 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 2.0 | BCD100322A11 | 517 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 4.0 | BCD100322A15 | 240 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 8.0 | BCD100322A19 | 286 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 12.0 | BCD100322A23 | 320 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | C | 24.0 | BCD100322A27 | 571 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 386 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 438 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 549 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 262 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 285 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 449 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 563 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 0.5 | BCD100322A04 | 343 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 1.0 | BCD100322A08 | 509 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 2.0 | BCD100322A12 | 323 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 4.0 | BCD100322A16 | 291 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 8.0 | BCD100322A20 | 278 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 12.0 | BCD100322A24 | 263 | pmol/sample |
| - | PE(38:5e)/PE(38:4p) | 25OH-Chol | 24.0 | BCD100322A28 | 643 | pmol/sample |